Protocol for Post Marketing Surveillance of Actilyse Vial

Terminated

Phase N/A Results N/A

Summary of Purpose

The objectives of this study are to review the safety and efficacy of Actilyse Vial (hereafter referred to as "Actilyse") in post-marketing use for treatment of acute ischemic stroke, through investigating followings; 1. Unknown adverse events (especially serious adverse events) 2. Frequency (Incidence) and trend of adverse events under the actual practice 3. Factors on the safety profile of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 August 2014.

1 Feb 2003 28 Aug 2014 1 Dec 2004 Unavailable 1 Aug 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts

Not available